BMO raises HealthEquity price target to $125
Bullish analyst revision with meaningful implied upside, but it remains a single-firm target estimate.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish analyst revision with meaningful implied upside, but it remains a single-firm target estimate.
What happened, with direct paths to the underlying reporting
BMO Capital raised its HQY target to $125 from $105, about 27% above the posted price of $98.37.
Target: $125
Posted price: $98.37
Analyst firm: BMO Capital
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.